August 31, 2014 3:19 AM ET


Company Overview of Aegera Therapeutics, Inc.

Company Overview

Aegera Therapeutics, Inc., a clinical-stage biotechnology company, develops targeted therapeutics for various unmet medical needs. The company focuses on preclinical and early-stage clinical development activities through integration of medicinal chemistry, biochemistry, cell biology, pharmacokinetics, and in vivo pharmacology/efficacy. Its products include HGS1029, a small molecule pan-inhibitor of apoptosis proteins (IAP) inhibitor to treat various cancers. The company’s preclinical stage programs targeting proteins involved in oncology and autoimmune/inflammatory diseases include small molecule Bruton's tyrosine kinase inhibitors, small molecule FMS (CSF-1R) kinase inhibitors, IAP inhibit...

810 chemin du Golf

Montreal, QC H3E 1A8


Founded in 1997





Key Executives for Aegera Therapeutics, Inc.

Scientific Founder
Scientific Founder
Scientific Founder
Scientific Founder
Scientific Founder
Compensation as of Fiscal Year 2014.

Aegera Therapeutics, Inc. Key Developments

Aegera Therapeutics, Inc. Presents at BIO-Europe 2012, Nov-12-2012

Aegera Therapeutics, Inc. Presents at BIO-Europe 2012, Nov-12-2012 . Venue: CCH Congress Center Hamburg, Am Dammtor / Marseiller Str, 20355 Hamburg, Germany.

Similar Private Companies By Industry

Company Name Region
Alethia BioTherapeutics Inc. Americas
TheraVitae Inc. Americas
BELLUS Health (Innodia) Inc. Americas
KLOX Technologies Inc. Americas
Technologie BiolActis Inc. Americas

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Aegera Therapeutics, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at